Modulation, Bioinformatic Screening, and Assessment of Small Molecular Peptides Targeting the Vascular Endothelial Growth Factor Receptor

Cell Biochemistry and Biophysics

Volumn 70, Issue 3, 2014, Pages 1913-1921

  Feng, Shibin ^a   Zou, Lingyun ^a   Ni, Qingshan ^a   Zhang, Xiang ^a   Li, Qianwei ^a   Zheng, Lei ^a   Xie, Laiping ^a   Li, Hongmin ^a   Huang, Dingde ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bioinformatics; Molecular probe; Tumor; Vegf VEGFR

Indexed keywords

PEPTIDE; PROTEIN BINDING; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; BINDING SITE; BIOLOGY; CHEMISTRY; CONFOCAL MICROSCOPY; HUMAN; IC50; METABOLISM; MOLECULAR DOCKING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; THERMODYNAMICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; HUMANS; INHIBITORY CONCENTRATION 50; MICROSCOPY, CONFOCAL; MOLECULAR DOCKING SIMULATION; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; THERMODYNAMICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84936744755     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0151-x     Document Type: Article

References (24)

1. Khosravi, S. P., & Fernández, P. I. (2008). Tumoral angiogenesis: Review of the literature. Cancer Investigation,26, 104–108.
2. Keedy, V. L., & Sandler, A. L. (2007). Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Cancer Science,98, 1825–1830.
3. Jia, B., Liu, Z., Shi, J., et al. (2008). Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer. Bioconjugate Chemistry,19, 201–210.
4. Liu, Z., Jia, B., Zhao, H., Chen, X., & Wang, F. (2011). Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models. Molecular Imaging and Biology,13, 112–120.
5. 188Re-RC-160. Nuclear Medicine and Biology,37, 977–987.
6. Zhang, K., Aruva, M. R., Shanthly, N., et al. (2007). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation. Regulatory Peptides,144, 91–100.
7. Kim, H., Zhai, G., Liu, Z., et al. (2011). Extracellular matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anti-Cancer Drugs,22, 864–874.
8. Liu, Z. J., Tian, R., Li, Y., et al. (2011). Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Annals of Surgery,254, 450–456.
9. Wood, L. M., Pan, Z. K., Guirnalda, P., Tsai, P., Seavey, M., & Paterson, Y. (2011). Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. Cancer Immunology, Immunotherapy,60, 931-42.
10. Choe, Y. S., & Lee, K. H. (2007). Targeted in vivo imaging of angiogenesis: Present status and perspectives. Current Pharmaceutical Design,13, 17–31.
11. Trinh, X. B., Tjalma, W. A., Vermeulen, P. B., et al. (2009). The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. British Journal of Cancer,100, 971–978.
12. Park, M. S., Ravi, V., & Araujo, D. M. (2010). Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Current Opinion in Oncology,22, 351–355.
13. Sallinen, H., Anttila, M., Narvainen, J., et al. (2009). Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Molecular Therapy,17, 278–284.
14. Ivy, S. P., Wick, J. Y., & Kaufman, B. M. (2009). An overview of small-molecule inhibitors of VEGFR signaling. Nature Reviews Clinical Oncology,6, 569–579.
15. Hsu, A. R., Cai, W., Veeravagu, A., et al. (2007). Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. Journal of Nuclear Medicine,48, 445–454.
16. Backer, M. V., Levashova, Z., Patel, V., et al. (2007). Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nature Medicine,13, 504–509.
17. Blankenberg, F. G., Backer, M. V., Levashova, Z., Patel, V., & Backer, J. M. (2006). In vivo tumor angiogenesis imaging with site-specific labeled (99 m)Tc-HYNIC-VEGF. European Journal of Nuclear Medicine and Molecular Imaging,33, 841–848.
18. Jia, H., Jezequel, S., Löhr, M., et al. (2001). Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Biochemical and Biophysical Research Communications,283, 164–173.
19. Bainbridge, J. W., Jia, H., Bagherzadeh, A., Selwood, D., Ali, R. R., & Zachary, I. (2003). A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation in vivo. Biochemical and Biophysical Research Communications,302, 793–799.
20. Qin, Z. X., Li, Q. X., Liu, G. Y., et al. (2009). Imaging targeted at tumor with 188Re labeled VEGF189 exon 6 encoded peptide and effects of the transfecting truncated KDR gene in tumor-bearing nude mice. Nuclear Medicine and Biology,36, 535–543.
21. Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry,31, 455–461.
22. Petsalaki, E., Stark, A., García-Urdiales, E., & Russell, R. B. (2009). Accurate prediction of peptide binding sites on protein surfaces. PLoS Computational Biology,5(3), e1000335.
23. Shibuya, M., & Claesson-Welsh, L. (2006). Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research,312, 549–560.
24. Ma, Y. P., Yang, Y., Zhang, S., et al. (2010). Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP. Journal of Experimental & Clinical Cancer Research,29, 56.